Imène Chebbi obtained a PhD in Chemistry and Biophysics from Sorbonne University (UPMC), which she defended in 2010. She joined the company Nanobacterie that same year.
She is specialised in nanoparticle formulation. She is in charge of the preclinical studies, focusing on efficacy and toxicity assessments.
